BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19075822)

  • 1. Enzymatic profiling of tetanus and botulinum neurotoxins based on vesicle-associated-membrane protein derived fluorogenic substrates.
    Perpetuo EA; Juliano L; Juliano MA; Fratelli F; Prado SM; Pimenta DC; Lebrun I
    Protein Pept Lett; 2008; 15(10):1100-6. PubMed ID: 19075822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.
    Schiavo G; Benfenati F; Poulain B; Rossetto O; Polverino de Laureto P; DasGupta BR; Montecucco C
    Nature; 1992 Oct; 359(6398):832-5. PubMed ID: 1331807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VAMP/synaptobrevin cleavage by tetanus and botulinum neurotoxins is strongly enhanced by acidic liposomes.
    Caccin P; Rossetto O; Rigoni M; Johnson E; Schiavo G; Montecucco C
    FEBS Lett; 2003 May; 542(1-3):132-6. PubMed ID: 12729912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
    Washbourne P; Pellizzari R; Baldini G; Wilson MC; Montecucco C
    FEBS Lett; 1997 Nov; 418(1-2):1-5. PubMed ID: 9414082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release.
    Schiavo G; Rossetto O; Montecucco C
    Semin Cell Biol; 1994 Aug; 5(4):221-9. PubMed ID: 7994006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.
    Sikorra S; Henke T; Galli T; Binz T
    J Biol Chem; 2008 Jul; 283(30):21145-52. PubMed ID: 18511418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
    Foran P; Shone CC; Dolly JO
    Biochemistry; 1994 Dec; 33(51):15365-74. PubMed ID: 7803399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How botulinum and tetanus neurotoxins block neurotransmitter release.
    Humeau Y; Doussau F; Grant NJ; Poulain B
    Biochimie; 2000 May; 82(5):427-46. PubMed ID: 10865130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolysis of synthetic peptides by type A botulinum neurotoxin.
    Schmidt JJ; Bostian KA
    J Protein Chem; 1995 Nov; 14(8):703-8. PubMed ID: 8747431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
    Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
    J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F.
    Schmidt JJ; Stafford RG
    Appl Environ Microbiol; 2003 Jan; 69(1):297-303. PubMed ID: 12514008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active-site mutagenesis of tetanus neurotoxin implicates TYR-375 and GLU-271 in metalloproteolytic activity.
    Rossetto O; Caccin P; Rigoni M; Tonello F; Bortoletto N; Stevens RC; Montecucco C
    Toxicon; 2001 Aug; 39(8):1151-9. PubMed ID: 11306125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tetanus and botulinum toxins are zinc metallopeptidases: molecular mechanisms and inhibition of their neurotoxicity].
    Cornille F; Roques BP
    J Soc Biol; 1999; 193(6):509-16. PubMed ID: 10783709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of VAMP Proteolysis by Tetanus and Botulinum Neurotoxin Type B In Vivo with a Cleavage-Specific Antibody.
    Fabris F; Šoštarić P; Matak I; Binz T; Toffan A; Simonato M; Montecucco C; Pirazzini M; Rossetto O
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins.
    Pellizzari R; Rossetto O; Lozzi L; Giovedi' S; Johnson E; Shone CC; Montecucco C
    J Biol Chem; 1996 Aug; 271(34):20353-8. PubMed ID: 8702770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetanus and botulism neurotoxins: a novel group of zinc-endopeptidases.
    Tonello F; Morante S; Rossetto O; Schiavo G; Montecucco C
    Adv Exp Med Biol; 1996; 389():251-60. PubMed ID: 8861019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetanus and botulism neurotoxins: a new group of zinc proteases.
    Montecucco C; Schiavo G
    Trends Biochem Sci; 1993 Sep; 18(9):324-7. PubMed ID: 7901925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative exosite-dependent cleavage of synaptobrevin by tetanus toxin light chain.
    Cornille F; Martin L; Lenoir C; Cussac D; Roques BP; Fournie-Zaluski MC
    J Biol Chem; 1997 Feb; 272(6):3459-64. PubMed ID: 9013591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of tetanus and botulinum neurotoxins.
    Montecucco C; Schiavo G
    Mol Microbiol; 1994 Jul; 13(1):1-8. PubMed ID: 7527117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
    Chen S; Hall C; Barbieri JT
    J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.